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EVALUATING THE ANTI-PROLIFERATIVE EFFECTS OF EXERCISE ON 
COLORECTAL CANCER CELL LINES HCT116 AND HT29 THROUGH 
TREATMENT OF MYOKINES PRODUCED FROM C2C12 CELLS 
SUBJECTED TO ELECTRIC PULSE STIMULATION 
 
TIMOTHY DON MAGNO LOPEZ 
ABSTRACT 
Background: Colorectal cancer incidence and mortality rates are rising and are 
still one of the most common cancers worldwide. Its risks are associated with the 
Western Lifestyle, important facets of this being increase physical inactivity and 
excess body weight. In sync with colorectal cancer’s increasing rates are obesity 
rates that are rising in both developed and developing countries. Obesity has 
been linked to several causes of death that includes cardiovascular disease and 
certain cancers. Studies have shown the benefits of exercise overtly in alleviating 
cardiovascular diseases but now have increasing evidence of its benefits in 
helping with cancer. Some studies have examined the effects of physical activity 
in colon cancer and have found a link between increase minutes of exercise 
weekly can slow cancer cell proliferation in colon crypts cells. Myokines are a 
newly discovered class of proteins that are produced by muscles and have 
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multiple functions. One of those function is its anti-neoplastic activity against 
certain cancer cell types. Certain myokines evoke an anti-neoplastic effect on 
cancer, but there has not been an overwhelming agreement within the scientific 
community.  
Objective: To investigate the anti-proliferative effects of exercise myokines 
produced by C2C12 cells in colorectal cancer cell lines: HCT116 and HT29, by 
looking at changes in protein expression through western blot analysis and 
protein arrays.  
Methods: C2C12 cells were grown in cell culture plates and differentiated into 
myotubules. Myotubules were subjected to Electronic Pulse Stimulation using an 
apparatus called C-Pace by Ion Optix to generate myokines. Treat HCT116 and 
HT29 cell lines with exercise myokines and a control treatment and ultimately 
harvest their protein lysate for western blot analysis and protein array analysis.  
Results: HCT116 treated with exercise myokines with different dilutions (1:25, 
1:50, 1:100) a demonstrated significantly decreased proliferation (p<0.0001). HT29 
treated with exercise myokines (1:25 dilution) also demonstrated a significant 
decrease in proliferation (p<0.0001). Western blot analysis of HCT116 treated 
with exercise myokines showed significantly lower expression in pRb (p<0.05), 
PCNA (p<0.05), and cyclin D1 (p<0.05). Western blot analysis of HT29 treated 
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with exercise myokines revealed significant expression downregulation in 
exercise myokine treatment in PCNA (p<0.05), p42/p44 (p<0.05), pRb (p<0.0001) 
and Cyclin D1 (p<0.05). Human Phospho-Kinase Array demonstrated 
downregulation of the following proteins in HT29 cells treated with exercise 
myokines: GSK-3a/b, STAT3, EGFR, p53, PDGF Rb, Src, PRAS40, WNK1, and 
JNK 1/2/3. Lastly, HT29 treated with exercise myokines showed downregulation 
of the p-EGFR and pHGFR as a result of the Human Phospho-RKT Array. 
Conclusion: Our data demonstrate that exercise myokines produced by Electric 
Pulse Stimulation of C2C12 cells have an anti-proliferative effect on colorectal 
cancer cell lines HCT116 and HT29. Further studies should be pursued to 
identifying and linking anti-proliferative properties to a specific myokine protein 
and confirming a pathway that this specific myokine exerts its effects.  
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INTRODUCTION 
 
Colorectal Cancer 
In a study published in 2009 by Melissa M. Center et al., it was observed 
that in developing countries with little support from the government or lack of 
any screening guidelines tend to have a lower incidence of CRC. Countries 
adopting Westernized Lifestyle, on the other hand, had an increase in frequency 
(Siegel 2018). Westernized lifestyle includes increase consumption of alcohol and 
red meat, low consumption of fiber, low intake of fruits and vegetables, obesity, 
physical inactivity and smoking (Arnold 2017, Siegel 2018). Countries adopting a 
Westernized lifestyle and increasing awareness of screening guidelines allow 
people to live longer which inevitably increases cancer incidence (Arnold 2017). 
There is an emerging trend in CRC incidence and deaths worldwide that were 
found by Melinda Arnold et al. (Arnold 2017) showing three distinct patterns. 
The Group I showed an increased incidence and mortality. Group II showed an 
increasing incidence and decreasing mortality. And Group III showed decreasing 
incidence and mortality. It was observed that a rising HDI, as well as 
westernization, coincided with an increase in CRC incidence (Arnold 2017, 
Center 2009). Limited health infrastructure, poor access to early detection and 
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treatment, delays in diagnosis, referral and treatment, cultural beliefs and 
financial constraints all contribute to the high mortality (Arnold 2017). 
  
Colorectal Cancer Patterns 
In a study published in 2009 by Melissa M. Center et al, it was observed 
that in developing countries with little support from the government and/or lack 
of any screening guidelines tend to have lower incidence of CRC. Countries 
adopting Westernized Lifestyle on the other hand had an increase in incidence 
(Siegel 2018). Westernized lifestyle includes increase consumption of alcohol and 
red meat, low consumption of fiber, low intake of fruits and vegetables, obesity, 
physical inactivity and smoking (Arnold 2017, Siegel 2018). Countries adopting a 
Westernized lifestyle and increasing awareness of screening guidelines allow 
people to live longer which inevitably increases cancer incidence (Arnold 2017). 
There is an emerging trend in CRC incidence and deaths worldwide that were 
found by Melinda Arnold et. al. (Arnold 2017) showing three distinct patterns. 
The Group I showed increasing incidence and mortality. Group II showed 
increasing incidence and decreasing mortality. And Group III showed decreasing 
incidence and mortality. It was observed that an increasing HDI as well as 
westernization coincided with an increase in CRC incidence (Arnold 2017, Center 
		 3 
2009). High mortality was attributed to limited health infrastructure, poor access 
to early detection and treatment, delays in diagnosis, referral and treatment, 
cultural beliefs and financial constraints (Arnold 2017). 
 
Obesity 
            Obesity has been linked to risk factors for several causes of death that 
include cardiovascular diseases (Charakida 2014, Prospective Studies 
Collaboration 2009), stroke (Prospective Studies Collaboration 2009), and several 
cancers: large intestine, kidney, endometrium, postmenopausal breast (Calle 
2003, Reeves 2007). Obesity prevalence has been increasing in both developing 
and developed countries (De Onis 2010, Stevens 2012, Mokdad 1999) and is 
attributable to the adoption of the Western lifestyle (Arnold 2017, Siegel 2018). 
This increase in obesity will continue to rise in developing countries and have 
attenuated in developed countries (Ng 2014). A facet of Westernization that 
drives weight gain in persons is the increased urbanization linked to a sedentary 
lifestyle (Popkin 1999, Swinburn 2009). Studies have estimated that there were 43 
million overweight and obese preschool children worldwide in 2010 (De Onis 
2010) and 1.46 billion overweight adults in 2008 (Stevens 2012). These studies (De 
Onis 2010, Stevens 2012) have also estimated the relative increase of obesity in 
		 4 
children and adults in a span of a few decades. From 1990 to 2010, the worldwide 
prevalence of childhood obesity had a corresponding increase of 60%, increased 
from 4.2% 6.7% (De Onis 2010). From 1980 to 2008, the worldwide prevalence of 
obesity in adults had a relative increase of 87.5%, increased from 6.4% to 12.0%. It 
is also important to note that the United States had the most significant increase 
in the number of obese people between 1980 to 2008 which was 56 million 
(Stevens 2012). Strengthening the idea that Western lifestyle is a significant factor 
in obesity. Bleich et al. (2008) investigated the increase in weight gain of adults in 
the US and found that it was attributable to overconsumption. The observed that 
technological innovation associated with food consumption is the prominent 
factor that drives weight gain in a developed world like the United States (Bleich 
2008). 
             An estimated 3.4 million deaths for persons with high BMI in 2010 (Lim 
2010), and with the obesity prevalence on the rise, it is essential to look at the 
downstream effects of having high adiposity to a person’s health. People in the 
higher BMI range, >25, is also associated with increased mortality for vascular 
(Prospective Studies Collaboration 2009), diabetes, non-neoplastic kidney, liver, 
neoplastic and respiratory diseases (Prospective Studies Collaboration 2009). 
Vascular, non-neoplastic kidney, and liver disease are associated with the 
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Figure 1: Worldwide incidence and mortality rate of colorectal cancer (Arnold 2017). 
 
 
 
 
 
 
 
 
 
 
		 6 
increased adiposity in obese persons. It was found that each 5 BMI points above 
25 have increased risks of these diseases as well. Increasing Westernization of 
developing countries leads to more sedentary lifestyles and an increase in food 
consumption is driving the BMI of the average person higher. A study in 2003 
(Fontaine 2003) showed that having high BMI has a deleterious on a person’s 
lifespan. Kevin R. Fontaine (Fontaine 2003) and co-authors were investigating the 
effects of severe obesity on a person’s lifespan. Results showed a discrepancy 
between the years of life lost (YLL) between white and black men and between 
men and women. White men with severe obesity (BMI >45) had YLL of 13, and 
white women had YLL of 8. 
            With the increasing Westernization of developing countries and 
technological advances, it is essential to look at obesity as a public health issue. 
Not only does obesity have damaging health effects by increasing adiposity, but 
this increase adiposity leads to other health problems that can decrease a 
person’s lifespan 
  
Physical Activity and Exercise 
            The current recommendation of the Physical Activity Guidelines for 
Americans (PAG) is that adults be involved in moderate-intensity aerobic 
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physical activity for 150-300 minutes in total per week in addition to muscle 
strengthening activities two or more times a week (Piercy 2018). An extensive 
array of studies has found that physical activity is associated with reduced risk of 
mortality of a range of causes (Piercy 2018, Kujala 1998, Paffenbarger 1993, Arem 
2015, Lee 2014, Wen 2011). However, only 22% of adults currently meet the 
recommended activity levels stated by PAG, and 36% reported having no 
leisure-time physical activity (Office of Disease Prevention and Health 
Promotion 2019). Furthermore, studies have shown that benefits related to 
physical activity is not only attainable when meeting the PAG guidelines but can 
be also beneficial to individuals who only perform smaller volumes of physical 
activity (Arem 2015, Lee 2014, Wen 2011) weekly. With all these positive effects, 
physical activity/exercise is a useful preventative measure for more than 20 
chronic conditions (Warburton 2006, Pedersen 2015). An essential part of 
validating these benefits are exercise intervention studies. A 12-month study by 
McTiernan et al. (2006) with participants of varying age for both men and 
women investigated colon crypt cell proliferation. Participants have prescribed a 
12-month exercise intervention involving moderate-to-vigorous exercise plan 
with >80% adherence. A trend of decrease in proliferation in colon crypts with 
increasing minutes of exercise per week was found 
		 8 
Table 1: Benefits and Outcomes of Maintaining Regular Physical Activity. A 
list of benefits regular physical can provide following exercise guidelines for 
adults provided by the American Heart Association (Piercy 2018). 
 
 
 
  
 
 
 
 
 
		 9 
Myokine 
The benefits of physical activity have been attributed to mechanisms such 
as increase VO2max and vasculature remodeling in muscle (Green 2012), 
reduction of circulating lipids (Haskell 1984, Tran 1983) decrease in body fat 
percentage (Tran 1983), decrease in inflammation (Starkie 2003) and muscle mass 
maintenance (Drummond 2009). Even though these mechanisms provide 
correlation to the bodily changes that happen during exercise, the exact role of 
contracting the skeletal muscle in mediation the benefits of exercise are still up 
for discussion. Goldstein (1961) was the first to suggests that muscle may release 
factors in response to the contraction that may affect other metabolic processes. It 
was not until Pedersen et al. (2003) linked IL-6 to be released after skeletal 
muscle contraction. It was Pedersen and his colleagues that suggested that 
cytokines and other peptides produced and liberated from muscle fibers be 
classified as myokines (Pederson 2003). 
            Myokines that have been studied and discovered have diverse roles. Some 
of the studies have shown IL-6, one of the most prominently studied myokines, 
have functions in increasing endogenous glucose production and clearance in 
humans during exercise (Febbraio 2004) and inflammation (Starkie 2003). 
Leukemia inhibitory factor (LIF) assists in the regulation of myotube 
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proliferation and differentiation (Broholm 2011). MCP-1 has a critical role in 
white blood cell (WBC) recruitment (Raschke 2013). Somatotropin is involved in 
metabolism via lipid mobilization (Raschke 2013). And others like Irisin 
(Bostrom 2012) and Meteorin-like protein (Rao 2014) stimulate energy 
expenditure by inducing browning of white adipose tissue. What all of them 
have in common is that their liberation is stimulated by contraction. 
            Most of the research in myokine used C2C12 mouse cells in combination 
with an Electric Pulse Stimulation (EPS) system that serves as the contraction 
stimulus (Furuichi 2018, Evers-van Gogh 2015). The differentiated C2C12 cells 
are treated with EPS with varying voltage and duration, and the media will 
contain the released myokines. This media is then used to treat cells of interest 
and investigators observe changes to cells with the EPS treated vs. non-EPS 
treated media (Evers-van Gogh 2015). 
 
Cancer Biomarkers 
Investigation of the physiology of cancer cells has elucidated proteins or 
biomarkers that help identify pathways that are unique to them. Cancer cells 
have altered physiology and express proteins that might not represent a normal 
cell. Munemitsu et al. (1995) showed that a mutant APC protein presented high 
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levels of cytoplasmic beta-catenin. Calvisi (2004) showed beta-catenin activation 
was associated with increased cell proliferation and tumor size. They are 
showing ultimately that activation of canonical Wnt signaling and beta-catenin 
provides proliferative rather than anti-apoptotic advantages in liver cancer. 
Therefore, in cancer cells, an increased level of Beta-catenin protein can be 
inferred. Research in biomarkers helps identify pathways in cancer cells that can 
be of therapeutic use through pharmacological intervention. 
 
SPECIFIC AIM 
 
 Physical activity has been proven to help with various chronic diseases 
including cancer. However, specific pathways, proteins or metabolic processes 
have not been delineated to attribute to the benefits of exercise.  
 This paper aims to continue to forge a link between the benefits of exercise 
and cancer by using murine C2C12 cells to produce an anti-proliferation effect on 
human colorectal cancer cell lines. Furthermore, this paper seeks to investigate 
various markers of proliferation on colorectal cancer cell lines treated with 
myokines produced from murine C2C12 cells.
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METHODS 
 
Cell Culture 
 Mouse Skeletal muscle C2C12 cells (ATCC, Manassas, VA) were cultured 
in DMEM (Invitrogen, Carlsbad, CA) containing 4.5 g/L glucose, L-glutamine 
and sodium pyruvate (Corning) supplemented with 10% heat-inactivated Fetal 
Bovine Serum (Invitrogen, Carlsbad, CA) and 2.5 mL Pen-Strep, 10,000 ug/mL of 
Penicillin and Streptomycin (Invitrogen, Carlsbad, CA). Differentiation was 
induced by switching to DMEM supplemented with 2% Horse serum 
(Invitrogen, Carlsbad, CA) 2.5 mL Pen-Strep, 10,000 ug/mL of Penicillin and 
Streptomycin and 100 ug of Insulin (Sigma Aldrich, St. Louis, MO) Cells were 
plated in a 6-well Cell Culture Plate. Differentiation was started when cells 
reached ~90% confluence (Day 0). 
Human colorectal cancer HCT116 and HT29 (ATCC, Manassas, VA) cells 
were cultured in McCoy’s 5A 1X Media containing L-glutamine (Invitrogen, 
Carlsbad, CA) supplemented with 10% FBS, 2.5 mL Pen-Strep, 10,000 ug/mL of 
Penicillin and Streptomycin. Cells were plated in a 6-well Cell Culture Plate and 
96-well plate. 
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Figure 2: Timeline of Myokine Generation using Murine C2C12 cells and Subsequent 
Treatment of Cancer Cell Lines with Generated Myokine Lot. Sequential steps of 
examining the effects of exercise via myokines generated from C2C12 cells.    
 
 
 
 
 
 
 
 
 
 
 
1 • Plate	immortalized	murine	C2C12	myoblast
2 • Grow	and	Differentiate	into	myotubules
3 • Myotubules	contracted	using	C-Pace	Apparatus	for	5	hours	or	not	contracted
4 • Media	is	collected	and	fractionated	using	Amicon®	ultra	centrifuge	filter	
5 • Cancer	cell	lines	treated	with	contracted	and	non-contracted	media	for	48	hrs	in	triplicate
6 • Perform	various	cell	and	molecular	biology	assays
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Myokine Production  
 C2C12 cells were allowed to differentiate for four days, and differentiation 
media was replaced only on the first day of differentiation. On day 4, the 
differentiation media was changed to regular growth media, DMEM containing 
FBS. Day 5, the day of contraction, DMEM is removed and replaced with Krebs 
Ringer Solution (Boston Bioproducts, Ashland, MA) after a DPBS (Invitrogen, 
Carlsbad, CA) 1X wash. C-Pace EP Cell Culture Stimulator (Ion Optix, Milton, 
MA) system was used to deliver electric pulse stimulation to the C2C12 cells. The 
conditions for the C-Pace Stimulation were: 25 V, 3.2 ms pulse duration, 2 Hz. 
Half of the plated C2C12 cells were stimulated, and half were not (control). 
C2C12 contraction duration was 5 hours. After contraction, the supernatant is 
collected and centrifuged for 5 minutes at room temperature and 1200 rpm. After 
centrifugation, the supernatant was retained while the pellet was discarded.  
The supernatant is then fractionated to preserve 10 kd proteins using Amicon® 
Ultra-15; Ultracel- 10K (MilliporeSigma, Burlington, MA) centrifuged for 70 
minutes at 4C and 4000 rpm. The resulting 10 kD fraction was used as a 
treatment for HCT116 cell lines at different dilutions. 
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Figure 3: C2C12 Myotubule During Various Stages of Differentiation. (A) C2C12 cells freshly 
plated at 40X magnification (B) C2C12 cells after two days of differentiation and starting to form 
myotubules at 40X magnification (C) C2C12 cells with mature and thicker myotubules indicated 
by the arrow after five days of differentiation right before treatment of EPS at 40X magnification 
(D) C2C12 cells after five days of differentiation at 100X magnification 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BA
DC
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Colorectal Cancer Cell Lines Treatment 
Fractionated myokines (stimulated and unstimulated conditions) are 
prepped in different dilutions for WST-1 assay. Dilutions used are 1:25, 1:50, 
1:100. 100 uL of diluted myokines were added to each well in the 96-well plate 
containing HCT116 cells with the corresponding conditions: SM: 1:25, 1:50, 1:100, 
UM: 1:25, 1:50, 1:100, and a media-only control. HT29 cells are treated with both 
SM and UM but only at a dilution of 1:25 for both. 
 
WST-1 Assay 
HCT116 cells and HT29 plated in a 96-well plate treated with fractionated 
myokines were incubated for 48-hours. The potency of myokines were assessed 
using the WST-1 assay. WST-1 reagent (Sigma Aldrich, St. Louis, MO) is light 
sensitive. It was prepared and performed with minimum light under the hood. 
WST-1 reagent was prepared by dilution 0.5mL of WST-1 reagent stock with 10 
mL of appropriate media. In each well, 250 uL of the prepped WST-1 reagent was 
added. The plate was covered with foil and incubated for 45 mins in an 
incubator.  The plate is then read using a plate reader at 440 nm with a reference 
of 630nm. After assessment of the potency, a dilution that decreased proliferation 
the most will be used to treat the 6-well plates. 
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Protein Preparation and Harvesting 
HCT116 cell lysates were prepared from 6-well plates after 48-hour 
incubation. Samples were kept on ice throughout the preparation of reagents. 
Cell lysis buffer 1X is prepared using Halt Protease & Phosphatase Inhibitor 
Cocktail 100X (ThermoFisher Scientific, Waltham, MA) and Cell Extraction (Life 
Technologies, Carlsbad, CA) solution. Before adding Cell Lysis buffer 1X, a cold 
PBS wash was performed. Samples are kept on ice, and 80 uL of 1X Cell lysis 
buffer is added and incubated for 10 minutes. Wells are scrapped and transferred 
to a 1.5 mL Eppendorf tube. Tubes are centrifuged for 10 minutes at 13,200 rpm 
at 4C. The supernatant is collected and was the lysate. 
 
Bradford Assay—Protein Quantification 
A protein standard curve is prepared using Bovine Serum Albumin 
2mg/mL (Bio-Rad, Hercules, CA). Eight concentrations of protein standards were 
prepared in the following concentrations: 2.0 mg/mL, 1.5 mg/mL, 1.0 mg/mL, 
0.75 mg/mL, 0.5 mg/mL, 0.125 mg/mL, and 0 mg/mL. In a 96-well, 5 uL is added 
in triplicate for each standard concentration. HCT116 lysates were added in 
duplicate and diluted 1:2 with molecular grade water. To each well, 250 uL of 
Bradford Reagent (Bio-Rad, Hercules, CA) was added and incubated in room 
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temperature for at least 5 minutes. The plate was then read using a plate reader 
reading the absorbance of light at 595 nm. Each well was measured and recorded 
in a Microsoft Excel spreadsheet.  
Protein lysates were standardized and stabilized by adding 1X cell lysis 
buffer and Lamelle buffer (Bio-Rad, Hercules, CA). Samples are then placed in 
boiling water for 5 minutes to denature and reduce all proteins. After, samples 
were then centrifuged at 13,200 rpm for 15 seconds and placed in -80C storage 
until ready to use. 
 
Western Blot 
Western blot analysis was performed on HCT116 cells treated with 
exercise media and control media after 48hr incubation. It is also performed on 
C2C12 cells post electrical stimulation by C-Pace ® apparatus (Ion Optix, 
Westwood, MA), including cells that were not electrically stimulated. Levels of 
AMPK and p-AMPK will be measured. Fractionated exercise media, 10kD cut 
off, will also be analyzed by western blot and look at Beta-actin.  
Transfer buffer was prepared ahead of time to cool it down. 
Approximately 2L of Transfer buffer will be required to run two pre-made gels 
(Bio-Rad, Hercules, CA). The transfer buffer consists of 10% 10X Transfer Buffer 
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(Boston BioProducts, Ashland, MA) 20% Methanol and 70% deionized water. 
The Transfer buffer needs to remain to be cold and is kept in -20C fridge as the 
rest of the western blot preparations are made. Running buffer 1X was prepared 
using Running Buffer 10X and diH2O using a 1:10 dilution. Samples were then 
thawed from -80C after quantification using Bradford’s assay. Samples were kept 
in ice after thaw as the SDS page apparatus was prepared.  
Pre-made SDS gels are used and inserted in SDS-Page apparatus, and 
Running Buffer is added up to the fill line indicated. The wells are then quickly 
washed using a disposable pipette with Running buffer. Each well was then 
loaded with standardized protein lysates that contained 60 ug of total protein. 
Protein standard (Invitrogen, Carlsbad, CA) and Magic Marker Standard 
(Invitrogen, Carlsbad, CA) was loaded on the first and last two wells. 
Electrophoresis was carried out using the apparatus with the power source at 
200V for 40 mins.  
The proteins separated were then transferred to PVDF membrane (Bio-
Rad, Hercules, CA). Wash the gel in Transfer Buffer for 5 minutes. The PVDF 
membrane is soaked in methanol for 10 seconds to be activated. The filter paper 
and sponges are immersed in transfer buffer until ready to use. The transfer 
apparatus is set up. The transfer was then carried out at 120 V for 60 minutes. 
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The whole transfer apparatus was immersed in ice to keep the transfer buffer 
cold.  
Prior to the transfer being done, TBSB/5% Blotto solution was prepared 
(Boston BioProducts, Ashland, MA). The transfer blot was immediately stained 
with Ponceau S (Boston BioProducts, Ashland, MA) then washed with diH2O 
three times. A final wash with TBST was done to remove any Ponceau S 
remaining. The blot was then blocked with TBST for an hour on a shaker. 
Primary antibody was prepared). The blocking TBST was replaced with new 
TBST with prepared primary antibody. The blot was left overnight to block on a 
rocker at +4C. 
Following 24h block with the primary antibody, the blot was washed 
three times with TBST, each wash lasting 5 minutes. The appropriate secondary 
antibody was then added and incubated. The blot was then rewashed three times 
with TBST, 5 minutes per wash. Luminal Enhancer (Santa Cruz Biotechnology, 
Dallas, TX) solution was prepared in a 1:1 ratio to develop the blot. The blot is 
incubated room temperature on a rocker for 1 minute. Excess luminal is drained, 
and the blot is read in UVP machine. 
 
Human Phospho-RTK Array and Human Phospho-Kinase Array Analyses 
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The Human Phospho-RTK Array Kit (R&D Systems, Minneapolis, MN) 
was used to determine the relative levels of tyrosine phosphorylation of 49 distinct 
RTKs. The Human Phospho-kinase Array Kit (R&D Systems, Minneapolis, MN) 
was used to determine the relative levels of phosphorylation of 43 different kinases 
and transcription factors. Briefly, HT29 cells were treated with exercise stimulated 
myokine media concentrate, and unstimulated media concentrate separately. 
After 48 hrs of treatment cells were lysed using RIPA buffer with protease inhibitor 
cocktail (ThermoFisher Scientific, Waltham, MA). The arrays were incubated with 
200-500 µg of protein lysate overnight at 4°C after blocking for 1 hour with Array 
Buffer 1 (R&D Systems, Minneapolis, MN). For Human Phosphor-RTK array, 
membranes were washed with 1X washing buffer and incubated with anti-
Phospho-Tyrosine-HRP Detection Antibody (1:5000) for 2 hours, and detection 
was done using Chemi Reagent Mix. For Human Phospho-Kinase array, the arrays 
were washed with 1X washing buffer and incubated with a cocktail of biotinylated 
detection antibodies. Detection was done using Streptavidin-HRP and Chemi 
Reagent Mix. Images were acquired via UVP Bio-imaging Systems and the data 
processed using ImageJ software (NIH). The data were normalized to the 
expression of positive controls, and average relative intensities (Pixel densities) 
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from each pair of duplicated spots were determined in relation to the negative 
control spots. 
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RESULTS 
 
WST-1 Assay—Myokine Potency 
HCT116 and HT29 cell lines are plated and treated for 48-hours with SM 
and UM. HCT116 cells treated for both SM and UM conditions and different 
concentrations for each displayed a significant decrease in proliferation (Figure 
4). The generated myokine produced was a highly potent lot that had strong 
anti-proliferative effects even at a low concentration (1:100 dilution). The SM 
treatment diluted 1:25 showed an 83.2% decrease in proliferation (p<0.0001). The 
treatment with 1:50 dilution demonstrated an 85.3% decrease in proliferation 
(p<0.0001). Lastly, there was a 65.2% decrease in proliferation for the treatment 
with 1:100 dilution (p<0.0001). 
HT29 cells 48-hour treatment of exercise myokines with a 1:25 dilution 
resulted in a significant decrease in proliferation (Figure 5). The SM treatment 
displayed an 88.9% decrease in proliferation (p<0.0001). 
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Figure 4: Effects of different myokine concentration on cell proliferation after 48-hour 
treatment of stimulated and unstimulated media on HCT116 cell line. WST-1 assay 
analysis of HCT116 cells showed decrease in proliferation in stimulated treatment in 
comparison to unstimulated treatment showed in decreasing concentrations.  
 
 
Figure 5: Effects of different myokine concentration on cell proliferation after 48-hour 
treatment of stimulated and unstimulated media on HT29 cell line. WST-1 assay analysis 
of HT29 cells demonstrated a significant decrease in proliferation in stimulated treatment.  
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Anti-Proliferative Marker Expression 
HCT116 48-hour Exercise Treatment Analysis 
Western blot analysis of HCT116 cells treated with SM and UM for 48 
hours demonstrated a significant downregulation of pRb, PCNA and Cyclin D1. 
The analysis also showed a non-significant downregulation of MEK 1/2 (Figure 6 
and Figure 7). Analysis SM treated HCT116 protein lysate in comparison to UM 
treatment showed a 73.4% decrease in expression of pRb (p<0.05), a 46.2% 
decrease in expression of PCNA, a 30.1% downregulation of MEK 1/2 (p>0.05) 
and an 86.2% downregulation in expression of Cyclin D1 (p<0.05). 
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Figure 6: Western Blot Gel of HCT116 Cell Line Protein Expression post 48-hour Treatment 
from Stimulated (Exercise) Media and Unstimulated (Control) Media. The actual gel comparing 
the bands of SM and UM treatment of pRb, a-Tubulin, pMEK 1/2, PCNA and Cyclin D1. 
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Figure 7: HCT116 Cell Line Western Blot Analysis of Protein Expression post 48-hour 
Treatment from Stimulated (Exercise) Media and Unstimulated (Control) Media. HT116 
cell lysate analysis via Western blot analysis comparing treatment of SM and UM revealed 
(A) pRb protein expression was significantly decreased in the stimulated treatment (B) 
PCNA protein expression was significantly decreased in the SM treatment compared to the 
unstimulated treatment (C) MEK1/2 expression demonstrated a non-significant decrease in 
the SM treatment (D) CyclinD1 protein expression demonstrated a significant decrease. 
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HT29 48-Hour Exercise Treatment Analysis 
The analysis of HT29 cells treated with SM and UM for 48-hours 
demonstrated downregulation of ß-catenin, PCNA, pRb, p42/p44 (pMAPK) and 
Cyclin D1 (Figure 8 and Figure 9). Analysis of the HT29 lysates treated with SM 
compared to UM demonstrated a 61.3% decrease in levels of ß-catenin expression 
(p<0.0001), a 25.4% decrease in expression of PCNA (p<0.05), an 80.9% decrease 
in expression of pRb (p<0.0001), a 52.3% decrease in p42/p44 (pMAPK) 
expression (p<0.05) and a 43.7% decrease in the expression of Cyclin D1 (p<0.05).
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Figure 8: Western Blot Gel of HT29 Cell Line Protein Expression post 48-hour Treatment from 
Stimulated (Exercise) Media and Unstimulated (Control) Media. The actual gel comparing the 
bands of SM and UM treatment of pRb, b-Catenin, a-Tubulin, pMAPK (p42/p44), Cyclin D1, and 
PCNA. 
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Figure 9: HT29 Cell Line Western Blot Analysis of Protein Expression post 48-hour Treatment from Stimulated (Exercise) Media and 
Unstimulated (Control) Media. HT29 cell lysate analysis via Western blot analysis of SM treatment in comparison to UM treatment 
revealed that after treatment (A) pb-Catenin showed a significant downregulation (B) PCNA expression had a significant decrease (C) 
pRb protein expression was significantly downregulated (D) pMAPK expression was significantly decreased (E) CyclinD1 expression was 
significantly downregulated. 
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Human Phospho-Kinase Array 
Identifying proteins markers that affect cell proliferation was done using 
phospho-kinase array comparing proteins from HCT-116 treated with SM and 
another treated with UM (Figure 10 and Figure 11). The protein array needed a 
minimum of 240 ug/mL of protein and thus required to pool three different protein 
samples for the stimulated and unstimulated condition. The protein array 
demonstrated 32.9% downregulation of GSK-3a/b, 57.3% downregulation of STAT3, 
46.8% decrease in EGFR expression, 81.9% decrease in p53 expression, 18.9% 
downregulation of PDGF Rb, 54.7% downregulation of Src, 33.8% decrease in 
expression of PRAS40, 21.0% downregulation of WNK1 and 20.3% downregulation of 
Jnk 1/2/3. There was also a 4.9% increase in expression of Akt 1/2/3. 
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Figure 10: Human Phospho-Kinase Array Developed Membrane on HT29 cells treated for 48-hours with Stimulated (Exercise) 
Media and Unstimulated (Control) Media. The actual membrane developed containing both HT29 cell lysate SM treatment and 
UM treatment demonstrating change in expression of the following proteins:  GSK-3a/ß, STAT3, EGFR, p53, PDGF-Rß, Src, 
PRAS40, WNK1, JNK 1/2/3, Akt 1/2/3.  
 
 
 
 
B
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Figure 11: Human Phospho-Kinase Array on HT29 cells treated for 48-hours with Stimulated (Exercise) Media and 
Unstimulated (Control) Media. HT29 cell lysate analysis demonstrated relative decrease in protein expression in SM treatment in 
comparison to UM treatment for the following proteins: (A) GSK-3a/ß, STAT3, EGFR, p53, PDGF-Rß, Src, PRAS40, WNK1, JNK 
1/2/3.  
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Human Phospho-RTK Array  
The protein array compared the different expressions of Inactivated kinases 
and receptor tyrosine kinase (RTK) between HT29 cells treated for 48-hours with SM 
and UM (Figure 12 and Figure 13). The protein array showed downregulation of 
pHGFR by 30% and downregulation of p-EGFR by 37%.
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Figure 12: Human Phospho-RTK Array Developed Membrane on HT29 cells treated for 48-hours with Stimulated (Exercise) 
Media and Unstimulated (Control) Media. HT29 lysate analysis revealed lower relative expression of p-HGFR and p-EGFR in the 
SM treatment (A) shows the relative change in expression between SM and UM treatment (B) developed membrane comparing the 
two treatments.  
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Figure 13: Human Phospho-RTK Array on HT29 cells treated for 48-hours with Stimulated 
(Exercise) Media and Unstimulated (Control) Media. HT29 lysate analysis revealed lower 
relative expression of p-HGFR and p-EGFR in the SM treatment (A) shows the relative 
change in expression between SM and UM treatment (B) developed membrane comparing 
the two treatments.  
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DISCUSSION 
 
This study results demonstrated myokines generated via electrical 
stimulation decrease cell proliferation in HCT116 and HT29 CRC cell lines. 
Electrical stimulation mimics exercise, and it allowed to study the effects of 
exercise in vitro. Significant findings of the study were (i) myokines produced 
through EPS C2C12 cells decreased cell proliferation of HCT116 cell line after a 
48-hour treatment, (ii) through western blot, cell cycle markers demonstrated a 
significant decrease in SM treatment, (iii) another demonstration of lower 
expression of specific proteins necessary for cell proliferation through Human 
Phospho-RTK Array and Human Phospho-Kinase Array. Stunted cell 
proliferation in growing HCT 116 and HT29 cells and decreased in essential cell 
cycle proteins all suggest a decrease in the health of CRC cell lines. Therefore, it 
can be inferred that exercise can be a viable prophylactic measure in preventing 
CRC. 
 
Anti-Proliferative Effect 
 Based on the WST-1 assay results, exercise simulated through EPS 
demonstrated an anti-proliferative effect on HCT116 cell line. The potency of 
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exercise fraction up to a dilution factor of 100 had a significant impact on 
HCT116 cell’s health. Further examining this anti-neoplastic effect through 
western blot analysis and protein arrays provide insight to which pathway 
myokines might be exerting its effects. Myokine treatment of HT29 cells results 
revealed downregulation of notable cell cycle proteins such as Beta-Catenin, pRb, 
Cyclin D1, STAT3, EGFR, and p53. Numerous pathways that might be affected 
by myokine treatment could be the MAPK pathway, EGFR pathway, and STAT3 
pathway. 
 
Cellular Pathways 
Based on the data gathered for this study, myokines exert their effects 
through different pathways. Results from the protein arrays showed 
downregulation of STAT3, Src, p-EGFR, JNK1/2/3 and are suggestive that 
myokines potentially work through the MAPK pathway in regulating cell 
proliferation. However, the data also demonstrates the downregulation of 
proteins in the canonical WNT pathway, GSK-3a/b, and b-catenin in the western 
blot analysis of HT29 treated with SM. Furthermore, there is also downregulation 
of pRb, Cyclin D1 and p53 proteins which is indicative of pathways involving 
tumor suppressors.  
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MAPK Pathway 
 MEK 1/2 is a protein in the MAPK pathway that we found downregulated 
after treatment of exercise myokines. MEK 1/2 is a kinase that phosphorylates 
ERK. ERK has both cytoplasmic and nuclear targets. Its nuclear targets are 
responsible, in normal functioning cells, for tumor suppression by inducing 
cellular senescence to cells that are stressed (Deschênes-Simard 2013) as well as 
promoting cell cycle progression (Zassadowski 2012). However, the data 
collected for this study did not show any significance to support the hypothesis 
exercise myokines utilizing MAPK pathway leading to an anti-proliferative 
effect. 
 
 Wnt Canonical Pathway 
 This pathway regulates cell proliferation, and inhibition of apoptosis once 
activated through the action of b-catenin. An essential regulator of this pathway 
is GSK-3b complex that phosphorylates b-catenin to target it for degradation 
(Yamamoto 1999). Mutation of b-catenin or critical regulators in this pathway 
leads to accumulation of free b-catenin in the cytoplasm. b-Catenin translocates 
to the nucleus and triggers its effects continuously (Polakis 2000). Elevated levels 
of  -catenin are then no surprised linked to increasing tumor size due to 
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increased cell proliferation (Calvisi 2004). The HT29 data collected found 
significant downregulation of b-catenin after treatment of exercise myokines 
(Figure 9) and also downregulation of GSK-3a/b in the protein array. This 
suggests that the Wnt canonical pathway be a potential route for exercise 
myokines’ actions. 
 Tumor Suppressors  
 TP53 is a critical tumor suppressor gene and is involved in preventing 
oncogenesis of cells through growth arrest and apoptosis (Nair 2004). Mutation 
in both alleles of the TP53 gene is also one of the most common mutations, all 
variants considered, in all of the human cancers (Bouaoun 2016). In HT29 cell 
treated with exercise myokines for 48-hours, the Phospho-Kinase Array 
displayed decrease p53. An increase in p53 would lead to growth arrest and 
apoptosis in cells. Downregulation of p53 by exercise myokines would be 
counter-productive as it would let cells divide instead of arrest when cancerous. 
Most p53 mutations are a loss of function mutations and do not fit with the idea 
of myokine acting as an anti-proliferative agent. 
  The western blot analysis of HT29 and HCT116 treated with SM for 48-
hours showed a significant downregulation for both pRb and Cyclin D1. Rb1 
gene is another critical tumor suppressor gene that is responsible for  
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Figure 14: CDK4/6-Rb pathway. The schematic model represents the Rb pathway where p53 and 
p16NK4A is inhibited in order for CDK4/6-Cyclin D complex to form, phosphorylate RB and E2F 
trigger the cell to proceed from G0/G1 phase to S-Phase (Pan 2017).  
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repressing (Brehm 1998) E2F inactivating processes involving DNA replication 
and repair (Ishida 2001). A loss of function of the Rb1 gene had been linked to 
tumorigenesis in the GI tract (Kucherlapati 2008). Increase in active Cyclin D1 in 
cells lead to progression to S-phase of cell division (Diehl 1997), and sustained 
upregulation of its expression is associated with abnormal growth and 
tumorigenicity of colon tumor cells (Arber 1997).  In the studies as mentioned 
earlier, both pRb and Cyclin D1 are upregulated in cancer cells. Upregulation of 
the expression of both proteins both leads to cell cycle progression of S-phase 
progression (Figure 14). Its downregulation with SM treatment, therefore, is a 
plausible mechanism for exercise myokines’ anti-proliferative effects.  
 
Myokines and EPS 
 Discovery of myokines is relatively new, and its field is still not well 
studied. The general usage of the C2C12 cell line for generating myokines 
simplifies the process and makes it efficiently replicated. However, it is still not 
equivalent to a biological system. Burch et al. (2010) tried to bridge the gap 
between an in vitro and in vivo system by examining the expression of PCG-1a 
in both C2C12 cultures and trained live mice. The team of authors did find 
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comparable effects for generating myokines through cell culture and a live 
animal.  
Another gap that needs to be addressed is myokine’s generation and 
action in humans. Proteins usually have a vast array of targets and effects in the 
body, and this makes the study of myokine difficult since the impact of a protein 
in vitro might not encompass a proteins actions in the human body. IL-6 levels 
increase after exercise and are produced from different organs that increase 
glucose clearance and production in humans (Febbraio 2004) and also has anti-
inflammatory activity (Starkie 2003). Some studies examine the production of 
myokine in human subjects. Besse-Patin et al. (2013) extracted muscle biopsies 
from participants and used those to grow a primary culture of human myoblasts 
that found an increase in mRNA expression of apelin. 
Lastly, it is crucial to determine the duration, current status and type 
physical exercise and which ultimately contributes to the beneficial effects of 
exercise. Walter et al. (2017) had tried to delineate if a person who was physically 
active when they were younger and not anymore still claimed benefits of 
exercise. They found that the latest (current) activity level correlated with 
increased survival for cancer survival but not lifetime (historical) activity level. 
Mathers et al. (2012) were able provided evidence in the different gene 
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expression of myokines after only performing a single bout of exercise through 
examining a muscle biopsy. However, Catoire et al. (2014) found that there are 
different myokines expressed between acute and exercise (chronic) exercise. 
Expression of myokines for each condition is different and did not overlap well. 
Furthermore, acute and chronic conditions elicited different bodily responses 
which makes attribution of exercise health benefits more difficult. 
 
Limitations 
A significant limitation of this study is the use of C2C12 cells. It is of 
murine origin and its plate in a two-dimensional manner. The myotubules that 
develop from these cells do not represent the 3D structure of myotubules in a 
human or matching species. There have been some papers that have 
demonstrated similar changes between an in vitro and in vivo system; 
nonetheless, results need validation using human subjects. 
Another limitation of the method of this study is the generation of 
myokines. Myokine treatments for each cell line used one batch. However, 
generating myokines varies batch to batch. The study used WST-1 to assess the 
potency of each myokine batch, but ultimately, each batch varies and can only be 
confirmed by further GC/MS analysis.  
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Finally, the study was not able to demonstrate a “chronic” condition for 
exercise using EPS. Studies have shown that there are unique differences 
between the expression of myokines in acute and chronic exercise. 
Future Work 
 The difference between SM and UM treatment showed significant 
differences, but the results do not elucidate a specific pathway that exercise 
myokine is undertaking. Future lab work includes focusing on understanding 
the molecular patterns of individual myokines and developing methods to 
investigate different components of generated myokines examined through mass 
spectroscopy. Also, using primary human muscle cells and comparing it to 
C2C12 to address any difference in using one over the other. 
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